REARDON ANDREW (CLO & Secretary) sold 1.5% of their position (500.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $57.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2025ACC: 0002001011-25-000048
Officer· CLO & Secretary
Since Mar 2026
-500.00
Net shares
Net seller
$57.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
500.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−500.00
Price / share
$114.08
Trade value
$57.04K
% of position
1.5%
6/23/2025
32.40K→31.90K
Total
Net shares
−500.00
Net value
-$57.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2025 | S · Sale | −500.00 | $114.08 | $57.04K | 1.5% | 32.40K | 31.90K |
| Total | −500.00 | -$57.04K | ||||||
Derivative Transactions0
No derivative transactions reported